Business Context and Reporting Period
This Form 8-K Current Report was filed by Xtant Medical Holdings, Inc. (XTNT) on April 10, 2025. The filing discloses a significant change in ownership structure involving the sale of approximately 73.1 million shares of common stock by majority stockholders affiliated with OrbiMed Advisors to funds affiliated with Nantahala Capital Management, LLC, and other investors.
Key Financial Metrics and Transaction Details
- Transaction Price: $0.42 per share.
- Shares Sold: Approximately 73.1 million shares.
- Post-Transaction Ownership: Nantahala Capital Management, LLC will hold 49.1% of the issued and outstanding common stock.
- Debt and Liquidity: The filing does not provide specific values for revenue, profit, cash flow, or total debt. However, it notes amendments to existing credit agreements with MidCap Financial Trust and MidCap Funding IV Trust.
Material Changes Versus Prior Period
The primary material change is the transfer of control from OrbiMed-affiliated entities to Nantahala-affiliated entities. To facilitate this transaction without triggering a "Change in Control" event under the Company's existing credit agreements, the definition of "Change in Control" was amended to increase the ownership threshold from 40% to 49.9%. This ensures Nantahala's 49.1% stake does not constitute a change in control.
Guidance, Outlook, and Agreements
- Registration Rights Agreement: The Company entered into an agreement to file a shelf resale registration statement within 30 days of closing, with efforts to have it declared effective within 60 days (or 90 days if reviewed by the SEC).
- Credit Agreement Amendments: Amendments No. 2 to the Term Loan and Revolving Loan agreements were executed solely to adjust the Change in Control threshold. All other borrowing terms remain unchanged.
- Outlook: The filing does not contain forward-looking financial guidance or management commentary regarding future operational performance.
Investor Verification Checklist
- Verify the closing date of the Stock Purchase Agreement and the final transfer of shares.
- Confirm the effectiveness of the Resale Registration Statement filed by the Company.
- Review the full text of the Credit Agreement Amendments (Exhibits 10.2 and 10.3) to ensure no other covenants were altered.
- Monitor subsequent filings for any impact on the Company's capital structure or liquidity following the transaction.